| 451 | BIOABioAge Labs, Inc. |
$9M |
-896.1% |
2025 |
| 452 | NSPRInspireMD, Inc. |
$9M |
-543.3% |
2025 |
| 453 | MLSSMilestone Scientific Inc. |
$9M |
-63.8% |
2025 |
| 454 | NNNNAnbio Biotechnology |
$8.6M |
74.1% |
2025 |
| 455 | ROIVRoivant Sciences Ltd. |
$8.3M |
-3,629.2% |
2025 |
| 456 | COYACoya Therapeutics, Inc. |
$7.9M |
-267.1% |
2025 |
| 457 | ACRSAclaris Therapeutics, Inc. |
$7.8M |
-829.6% |
2025 |
| 458 | CRNXCrinetics Pharmaceuticals, Inc. |
$7.7M |
-6,046.2% |
2025 |
| 459 | ADAGAdagene Inc. |
$7.7M |
-229.6% |
2025 |
| 460 | XENEXenon Pharmaceuticals Inc. |
$7.5M |
-4,612.1% |
2025 |
| 461 | OVIDOvid Therapeutics Inc. |
$7.3M |
-240.1% |
2025 |
| 462 | WHWKWhitehawk Therapeutics, Inc. |
$7.1M |
-288.3% |
2025 |
| 463 | IMNMImmunome Inc. |
$6.9M |
-3,060.0% |
2025 |
| 464 | EUDAEUDA Health Holdings Ltd |
$6.8M |
-40.7% |
2025 |
| 465 | FATEFate Therapeutics Inc |
$6.6M |
-2,051.1% |
2025 |
| 466 | KRROKorro Bio, Inc. |
$6.4M |
-1,834.5% |
2025 |
| 467 | HSDTSolana Co |
$6M |
-679.6% |
2025 |
| 468 | ABEOAbeona Therapeutics Inc. |
$5.8M |
1,223.1% |
2025 |
| 469 | LUCDLucid Diagnostics Inc. |
$4.7M |
-1,232.7% |
2025 |
| 470 | PRMEPrime Medicine, Inc. |
$4.6M |
-4,342.4% |
2025 |
| 471 | OCGNOcugen, Inc. |
$4.4M |
-1,537.4% |
2025 |
| 472 | CPHIChina Pharma Holdings, Inc. |
$4.1M |
-76.9% |
2025 |
| 473 | ATAIAtaiBeckley Inc. |
$4.1M |
-16,142.0% |
2025 |
| 474 | IMDXInsight Molecular Diagnostics Inc. |
$4.1M |
-1,238.5% |
2025 |
| 475 | CGONCG Oncology, Inc. |
$4M |
-3,985.0% |
2025 |
| 476 | CRVOCervoMed Inc. |
$4M |
-673.1% |
2025 |
| 477 | ACIUAC Immune SA |
CHF 3.6M |
-1,971.6% |
2025 |
| 478 | NRXSNeuraxis, INC |
$3.6M |
-218.5% |
2025 |
| 479 | CRSPCRISPR Therapeutics AG |
$3.5M |
-16,569.8% |
2025 |
| 480 | CAMPCamp4 Therapeutics Corp |
$3.5M |
-2,298.5% |
2025 |
| 481 | SRZNSurrozen, Inc. |
$3.5M |
-6,960.8% |
2025 |
| 482 | UPBUpstream Bio, Inc. |
$2.9M |
-5,026.0% |
2025 |
| 483 | ABSIAbsci Corp |
$2.8M |
-4,113.7% |
2025 |
| 484 | RNACCartesian Therapeutics, Inc. |
$2.8M |
-4,658.6% |
2025 |
| 485 | ALGSAligos Therapeutics, Inc. |
$2.2M |
-1,106.7% |
2025 |
| 486 | HUMAHumacyte, Inc. |
$2M |
-2,003.6% |
2025 |
| 487 | NTRBNutriBand Inc. |
$2M |
-404.1% |
2026 |
| 488 | DNTHDianthus Therapeutics, Inc. |
$2M |
-7,973.3% |
2025 |
| 489 | ORMPOramed Pharmaceuticals Inc. |
$2M |
3,202.5% |
2025 |
| 490 | AVRAnteris Technologies Global Corp. |
$1.9M |
-4,921.3% |
2025 |
| 491 | RANIRani Therapeutics Holdings, Inc. |
$1.6M |
-1,817.1% |
2025 |
| 492 | CLDXCelldex Therapeutics, Inc. |
$1.5M |
-16,748.0% |
2025 |
| 493 | DXRDaxor Corp |
$1.4M |
-496.8% |
2011 |
| 494 | NRXPNRX Pharmaceuticals, Inc. |
$1.4M |
-1,980.8% |
2025 |
| 495 | OTLKOutlook Therapeutics, Inc. |
$1.4M |
-4,416.2% |
2025 |
| 496 | ONMDOneMedNet Corp |
$1.4M |
-206.1% |
2025 |
| 497 | INBXInhibrx Biosciences, Inc. |
$1.3M |
-10,773.5% |
2025 |
| 498 | RNXTRenovoRx, Inc. |
$1.1M |
-994.5% |
2025 |
| 499 | STTKShattuck Labs, Inc. |
$1M |
-4,880.9% |
2025 |
| 500 | RFLRafael Holdings, Inc. |
$917K |
-3,328.2% |
2025 |